OmniAb (OABI) Change in Accured Expenses (2021 - 2026)
OmniAb (OABI) reported Change in Accured Expenses of -$2.5 million for Q1 2026, up 15.03% year-over-year from -$2.2 million in Q1 2025, and down 300.16% quarter-over-quarter from $1.3 million in Q4 2025.
OmniAb (OABI) Change in Accured Expenses (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Change in Accured Expenses data on file, last reported at -$2.5 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$2.5 million, up 15.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $215000.0 (up 111.0% YoY), and the FY2025 annual result was -$231000.0, up 90.41% from the prior year.
- Change in Accured Expenses eased to -$2.5 million in Q1 2026 per OABI's latest filing, from $1.3 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $14.6 million in Q4 2022 and troughed at -$3.4 million in Q1 2024.
- A 5-year average of $636764.7 and a median of $280000.0 in 2025 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 2257.45% in 2023, then plunged 114.8% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $14.6 million in 2022, then slumped by 103.59% to -$526000.0 in 2023, then surged by 247.53% to $776000.0 in 2024, then jumped by 62.37% to $1.3 million in 2025, then tumbled by 300.16% to -$2.5 million in 2026.
- Business Quant data shows OABI's Change in Accured Expenses at -$2.5 million in Q1 2026, $1.3 million in Q4 2025, and $280000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | -2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.52 Mn |
| Mar 31, 2026 | -2.52 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 280,000.00 |
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | -2.97 Mn |
| Mar 31, 2025 | -2.97 Mn |
| Dec 31, 2024 | 776,000.00 |
| Dec 31, 2024 | 776,000.00 |
| Sep 30, 2024 | 402,000.00 |
| Sep 30, 2024 | 402,000.00 |
| Jun 30, 2024 | -164,000.00 |
| Jun 30, 2024 | -164,000.00 |
| Mar 31, 2024 | -3.42 Mn |
| Mar 31, 2024 | -3.42 Mn |
| Dec 31, 2023 | -526,000.00 |
| Dec 31, 2023 | -526,000.00 |